Wellington Management Group LLP Has $4.89 Billion Stock Holdings in Danaher Co. (NYSE:DHR)

Wellington Management Group LLP decreased its position in Danaher Co. (NYSE:DHR) by 8.5% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 21,318,827 shares of the conglomerate’s stock after selling 1,987,430 shares during the period. Danaher comprises approximately 0.9% of Wellington Management Group LLP’s holdings, making the stock its 14th largest holding. Wellington Management Group LLP’s holdings in Danaher were worth $4,893,737,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. Howard Capital Management Group LLC increased its holdings in Danaher by 4.1% in the 3rd quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate’s stock valued at $342,000 after buying an additional 48 shares during the period. CreativeOne Wealth LLC boosted its position in shares of Danaher by 24.7% during the 3rd quarter. CreativeOne Wealth LLC now owns 1,542 shares of the conglomerate’s stock valued at $429,000 after acquiring an additional 305 shares in the last quarter. Public Sector Pension Investment Board increased its stake in Danaher by 27.7% in the third quarter. Public Sector Pension Investment Board now owns 24,903 shares of the conglomerate’s stock valued at $6,924,000 after acquiring an additional 5,400 shares during the period. Edgestream Partners L.P. raised its position in Danaher by 466.1% in the third quarter. Edgestream Partners L.P. now owns 10,965 shares of the conglomerate’s stock worth $3,048,000 after purchasing an additional 9,028 shares in the last quarter. Finally, Bellevue Group AG lifted its stake in Danaher by 25.8% during the third quarter. Bellevue Group AG now owns 105,590 shares of the conglomerate’s stock worth $29,356,000 after purchasing an additional 21,670 shares during the period. Institutional investors own 79.05% of the company’s stock.

Insider Activity at Danaher

In related news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the sale, the senior vice president now owns 20,230 shares in the company, valued at $4,534,149.90. This represents a 21.98 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 11.10% of the stock is currently owned by corporate insiders.

Danaher Price Performance

Shares of DHR stock opened at $205.69 on Monday. The firm’s 50 day moving average price is $214.57 and its two-hundred day moving average price is $236.39. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. Danaher Co. has a 52-week low of $196.80 and a 52-week high of $281.70. The stock has a market cap of $147.01 billion, a PE ratio of 38.96, a PEG ratio of 2.66 and a beta of 0.82.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period last year, the company posted $2.09 EPS. As a group, analysts forecast that Danaher Co. will post 7.63 EPS for the current year.

Danaher Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a $0.32 dividend. The ex-dividend date is Friday, March 28th. This is a boost from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.62%. Danaher’s dividend payout ratio is 24.24%.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on DHR shares. Guggenheim initiated coverage on Danaher in a report on Thursday, December 19th. They issued a “buy” rating and a $275.00 target price for the company. Royal Bank of Canada reiterated an “outperform” rating and set a $277.00 price objective (down from $299.00) on shares of Danaher in a research note on Thursday, January 30th. Scotiabank assumed coverage on shares of Danaher in a research note on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 target price on the stock. Wells Fargo & Company cut their price target on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating for the company in a report on Thursday, January 30th. Finally, JPMorgan Chase & Co. decreased their price objective on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Five analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $278.24.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.